Intraneuronal beta-Amyloid Aggregates, Neurodegeneration, and Neuron Loss in Transgenic Mice with Five Familial Alzheimer's Disease Mutations: Potential Factors in Amyloid Plaque Formation, Journal of Neuroscience, vol.26, issue.40, pp.10129-10140, 2006. ,
DOI : 10.1523/JNEUROSCI.1202-06.2006
The Amyloid Hypothesis of Alzheimer's Disease: Progress and Problems on the Road to Therapeutics, Science, vol.297, issue.5580, pp.353-356, 2002. ,
DOI : 10.1126/science.1072994
Dynamic Analysis of Amyloid ??-Protein in Behaving Mice Reveals Opposing Changes in ISF versus Parenchymal A?? during Age-Related Plaque Formation, Journal of Neuroscience, vol.31, issue.44, pp.15861-15869, 2011. ,
DOI : 10.1523/JNEUROSCI.3272-11.2011
Biochemistry of Amyloid ??-Protein and Amyloid Deposits in Alzheimer Disease, Cold Spring Harbor Perspectives in Medicine, vol.2, issue.6, p.6262, 2012. ,
DOI : 10.1101/cshperspect.a006262
Neurotoxicity of Amyloid ??-Protein: Synaptic and Network Dysfunction, Cold Spring Harbor Perspectives in Medicine, vol.2, issue.7, p.6338, 2012. ,
DOI : 10.1101/cshperspect.a006338
Systematic Evaluation of Candidate Ligands Regulating Ectodomain Shedding of Amyloid Precursor Protein, Biochemistry, vol.52, issue.19, pp.3264-3277, 2013. ,
DOI : 10.1021/bi400165f
Impairments in remote memory stabilization precede hippocampal synaptic and cognitive failures in 5XFAD Alzheimer mouse model, Neurobiology of Disease, vol.33, issue.2, pp.229-235, 2009. ,
DOI : 10.1016/j.nbd.2008.10.006
Area-Specific Alterations of Synaptic Plasticity in the 5XFAD Mouse Model of Alzheimer???s Disease: Dissociation between Somatosensory Cortex and Hippocampus, PLoS ONE, vol.27, issue.9, p.74667, 2013. ,
DOI : 10.1371/journal.pone.0074667.g003
Sex- and brain region-specific acceleration of ??-amyloidogenesis following behavioral stress in a mouse model of Alzheimer's disease, Molecular Brain, vol.3, issue.1, p.34, 2010. ,
DOI : 10.1186/1756-6606-3-34
Phospho-eIF2?? Level Is Important for Determining Abilities of BACE1 Reduction to Rescue Cholinergic Neurodegeneration and Memory Defects in 5XFAD Mice, PLoS ONE, vol.5, issue.9, p.12974, 2010. ,
DOI : 10.1371/journal.pone.0012974.g005
Sominone Improves Memory Impairments and Increases Axonal Density in Alzheimer's Disease Model Mice, 5XFAD, International Journal of Neuroscience, vol.30, issue.3, pp.181-190, 2011. ,
DOI : 10.3109/00207454.2010.541571
Motor deficits, neuron loss, and reduced anxiety coinciding with axonal degeneration and intraneuronal Abeta aggregation in the 5XFAD mouse model of Alzheimer's disease, Neurobiol Aging, vol.33, pp.196-129, 2012. ,
Mechanisms that lessen benefits of beta-secretase reduction in a mouse model of Alzheimer's disease. Transl Psychiatry, p.284, 2013. ,
Evidence for early cognitive impairment related to frontal cortex in the 5XFAD mouse model of Alzheimer's disease, J Alzheimers Dis, vol.33, pp.781-796, 2013. ,
Early administration of RS 67333, a specific 5-HT4 receptor agonist, prevents amyloidogenesis and behavioral deficits in the 5XFAD mouse model of Alzheimer???s disease, Frontiers in Aging Neuroscience, vol.5, p.96, 2013. ,
DOI : 10.3389/fnagi.2013.00096
PKC ?? Activation Prevents Synaptic Loss, A?? Elevation, and Cognitive Deficits in Alzheimer's Disease Transgenic Mice, Journal of Neuroscience, vol.31, issue.2, pp.630-643, 2011. ,
DOI : 10.1523/JNEUROSCI.5209-10.2011
????-Secretase-1 elevation in transgenic mouse models of Alzheimer??????s disease is associated with synaptic/axonal pathology and amyloidogenesis: implications for neuritic plaque development, European Journal of Neuroscience, vol.27, issue.12, pp.2271-2283, 2009. ,
DOI : 10.1111/j.1460-9568.2009.07017.x
Postsynaptic degeneration as revealed by PSD-95 reduction occurs after advanced A?? and tau pathology in transgenic mouse models of Alzheimer???s disease, Acta Neuropathologica, vol.30, issue.3, pp.285-292, 2011. ,
DOI : 10.1007/s00401-011-0843-x
Failures to reconsolidate memory in a mouse model of Alzheimer???s disease, Neurobiology of Learning and Memory, vol.92, issue.3, pp.455-459, 2009. ,
DOI : 10.1016/j.nlm.2009.05.001
Onset of hippocampus-dependent memory impairments in 5XFAD transgenic mouse model of Alzheimer's disease, Hippocampus, vol.29, issue.7, pp.762-772, 2014. ,
DOI : 10.1002/hipo.22267
Spine pruning in 5xFAD mice starts on basal dendrites of layer 5 pyramidal neurons, Brain Structure and Function, vol.2, issue.3, pp.571-580, 2014. ,
DOI : 10.1007/s00429-013-0518-6
Synaptic deficits in layer 5 neurons precede overt structural decay in 5xFAD mice, Neuroscience, vol.254, pp.152-159, 2013. ,
DOI : 10.1016/j.neuroscience.2013.09.016
Neuron loss in the 5XFAD mouse model of Alzheimer's disease correlates with intraneuronal Abeta42 accumulation and Caspase-3 activation, Mol Neurodegener, vol.8, issue.2, 2013. ,
Gene expression profiles of transcripts in amyloid precursor protein transgenic mice: up-regulation of mitochondrial metabolism and apoptotic genes is an early cellular change in Alzheimer's disease, Human Molecular Genetics, vol.13, issue.12, pp.1225-1240, 2004. ,
DOI : 10.1093/hmg/ddh140
Transcriptome Differences Between the Frontal Cortex and Hippocampus of Wild-Type and Humanized Presenilin-1 Transgenic Mice, The American Journal of Geriatric Psychiatry, vol.13, issue.12, pp.1041-1051, 2005. ,
DOI : 10.1097/00019442-200512000-00003
Presenilin-1-Dependent Transcriptome Changes, Journal of Neuroscience, vol.25, issue.6, pp.1571-1578, 2005. ,
DOI : 10.1523/JNEUROSCI.4145-04.2005
Age-related changes in brain metabolites and cognitive function in APP/PS1 transgenic mice, Behavioural Brain Research, vol.235, issue.1, pp.1-6, 2012. ,
DOI : 10.1016/j.bbr.2012.07.016
Analysis of differential plaque depositions in the brains of Tg2576 and Tg-APPswe/PS1dE9 transgenic mouse models of Alzheimer disease, Experimental & Molecular Medicine, vol.50, issue.8, pp.492-502, 2012. ,
DOI : 10.3858/emm.2012.44.8.056
Early and sustained altered expression of aging-related genes in young 3xTg-AD mice, Cell Death and Disease, vol.58, issue.2, p.1054, 2014. ,
DOI : 10.1038/nrneurol.2012.156
RNA-Seq analysis of frontal cortex and cerebellum from 5XFAD mice at early stage of disease pathology, J Alzheimers Dis, vol.29, pp.793-808, 2012. ,
Deciphering the molecular profile of plaques, memory decline and neuron loss in two mouse models for Alzheimer's disease by deep sequencing, Front Aging Neurosci, vol.6, p.75, 2014. ,
Transthyretin sequesters amyloid beta protein and prevents amyloid formation., Proceedings of the National Academy of Sciences, vol.91, issue.18, pp.8368-8372, 1994. ,
DOI : 10.1073/pnas.91.18.8368
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC44607
Accelerated A?? Deposition in APPswe/PS1??E9 Mice with Hemizygous Deletions of TTR (Transthyretin), Journal of Neuroscience, vol.27, issue.26, pp.7006-7010, 2007. ,
DOI : 10.1523/JNEUROSCI.1919-07.2007
Soluble amyloid precursor protein (APP) regulates transthyretin and Klotho gene expression without rescuing the essential function of APP, Proceedings of the National Academy of Sciences, vol.107, issue.40, pp.17362-17367, 2010. ,
DOI : 10.1073/pnas.1012568107
Lack of neurodegeneration in transgenic mice overexpressing mutant amyloid precursor protein is associated with increased levels of transthyretin and the activation of cell survival pathways, J Neurosci, vol.22, pp.7380-7388, 2002. ,
Mutation of the mouse klotho gene leads to a syndrome resembling ageing, Nature, vol.390, issue.6655, pp.45-51, 1997. ,
DOI : 10.1038/36285
Suppression of Aging in Mice by the Hormone Klotho, Science, vol.309, issue.5742, pp.1829-1833, 2005. ,
DOI : 10.1126/science.1112766
??-Klotho as a Regulator of Calcium Homeostasis, Science, vol.316, issue.5831, pp.1615-1618, 2007. ,
DOI : 10.1126/science.1135901
Differential Sensitivity of Murine Astrocytes and Neurons from Different Brain Regions to Injury, Experimental Neurology, vol.169, issue.2, pp.416-424, 2001. ,
DOI : 10.1006/exnr.2001.7678
From development to dysfunction: Microglia and the complement cascade in CNS homeostasis, Ageing Research Reviews, vol.12, issue.3, pp.749-756, 2013. ,
DOI : 10.1016/j.arr.2013.02.001
Microglial dysfunction in brain aging and Alzheimer's disease, Biochemical Pharmacology, vol.88, issue.4, pp.594-604, 2014. ,
DOI : 10.1016/j.bcp.2014.01.008
Human CNS immune senescence and neurodegeneration, Current Opinion in Immunology, vol.29, pp.93-96, 2014. ,
DOI : 10.1016/j.coi.2014.05.005
Genetic reductions of ????-site amyloid precursor protein-cleaving enzyme??????1 and amyloid-???? ameliorate impairment of conditioned taste aversion memory in 5XFAD Alzheimer??????s disease model mice, European Journal of Neuroscience, vol.27, issue.Suppl 2, pp.110-118, 2010. ,
DOI : 10.1111/j.1460-9568.2009.07031.x
Mitochondrial dysfunction and accumulation of the ??-secretase-cleaved C-terminal fragment of APP in Alzheimer's disease transgenic mice, Neurobiology of Disease, vol.45, issue.1, pp.417-424, 2012. ,
DOI : 10.1016/j.nbd.2011.09.001
Tumor necrosis factor-?? triggers a cytokine cascade yielding postoperative cognitive decline, Proceedings of the National Academy of Sciences, vol.107, issue.47, pp.20518-20522, 2010. ,
DOI : 10.1073/pnas.1014557107
Role of interleukin-1?? in postoperative cognitive dysfunction, Annals of Neurology, vol.410, issue.3, pp.360-368, 2010. ,
DOI : 10.1002/ana.22082
Does neuroinflammation fan the flame in neurodegenerative diseases?, Molecular Neurodegeneration, vol.4, issue.1, p.47, 2009. ,
DOI : 10.1186/1750-1326-4-47
Cytokines and Brain Injury: Invited Review, Journal of Intensive Care Medicine, vol.25, issue.9, pp.236-249, 2008. ,
DOI : 10.1177/0885066608318458
Opposing Roles for Reactive Astrocytes following Traumatic Brain Injury, Neurosignals, vol.16, issue.2-3, pp.154-164, 2008. ,
DOI : 10.1159/000111560
Modulation of immune response by head injury, Injury, vol.38, issue.12, pp.1392-1400, 2007. ,
DOI : 10.1016/j.injury.2007.10.005
Closed head injury???an inflammatory disease?, Brain Research Reviews, vol.48, issue.2, pp.388-399, 2005. ,
DOI : 10.1016/j.brainresrev.2004.12.028
A CD11d Monoclonal Antibody Treatment Reduces Tissue Injury and Improves Neurological Outcome after Fluid Percussion Brain Injury in Rats, Journal of Neurotrauma, vol.29, issue.14, pp.2375-2392, 2012. ,
DOI : 10.1089/neu.2012.2408
Fibrillar Amyloid-?? Peptides Activate Microglia via TLR2: Implications for Alzheimer's Disease, The Journal of Immunology, vol.181, issue.10, pp.7254-7262, 2008. ,
DOI : 10.4049/jimmunol.181.10.7254
No improvement after chronic ibuprofen treatment in the 5XFAD mouse model of Alzheimer's disease, Neurobiology of Aging, vol.33, issue.4, pp.833-839, 2012. ,
DOI : 10.1016/j.neurobiolaging.2011.08.006
Activation of the classical complement pathway in brain tissue of Alzheimer patients, Neuroscience Letters, vol.107, issue.1-3, pp.341-346, 1989. ,
DOI : 10.1016/0304-3940(89)90843-4
Contribution of complement activation pathways to neuropathology differs among mouse models of Alzheimer's disease, Journal of Neuroinflammation, vol.8, issue.1, p.4, 2011. ,
DOI : 10.1186/1742-2094-8-4
Cerebrospinal fluid levels of complement proteins C3, C4 and CR1 in Alzheimer???s disease, Journal of Neural Transmission, vol.154, issue.3, pp.789-797, 2012. ,
DOI : 10.1007/s00702-012-0797-8
Alzheimer's beta-amyloid peptides can activate the early components of complement classical pathway in a C1q-independent manner, Clinical and Experimental Immunology, vol.121, issue.3, pp.526-533, 1999. ,
DOI : 10.1038/380168a0
Activation of complement and contact system in Alzheimer's disease, Mechanisms of Ageing and Development, vol.122, issue.16, pp.1971-1983, 2001. ,
DOI : 10.1016/S0047-6374(01)00311-6
Neuroprotection from Complement-Mediated Inflammatory Damage, Annals of the New York Academy of Sciences, vol.1035, issue.1, pp.147-164, 2004. ,
DOI : 10.1196/annals.1332.010
Complement Activation in Very Early Alzheimer Disease, Alzheimer Disease & Associated Disorders, vol.19, issue.2, pp.55-66, 2005. ,
DOI : 10.1097/01.wad.0000165506.60370.94
URL : https://hal.archives-ouvertes.fr/hal-00077828
Microglia, Alzheimer's Disease, and Complement, International Journal of Alzheimer's Disease, vol.60, issue.6, p.983640, 2012. ,
DOI : 10.1111/j.1471-4159.2007.05012.x
Occurrence of T cells in the brain of Alzheimer's disease and other neurological diseases, Journal of Neuroimmunology, vol.124, issue.1-2, pp.83-92, 2002. ,
DOI : 10.1016/S0165-5728(01)00496-9
T-Cells in Alzheimer's Disease, NeuroMolecular Medicine, vol.7, issue.3, pp.255-264, 2005. ,
DOI : 10.1385/NMM:7:3:255
The innate and adaptive immunological aspects in neurodegenerative diseases, Journal of Neuroimmunology, vol.269, issue.1-2, pp.1-8, 2014. ,
DOI : 10.1016/j.jneuroim.2013.09.020
Neuroinflammation and Brain Functional Disconnection in Alzheimer???s Disease, Frontiers in Aging Neuroscience, vol.5, p.81, 2013. ,
DOI : 10.3389/fnagi.2013.00081
What does complement do in Alzheimer???s disease? Old molecules with new insights, Translational Neurodegeneration, vol.2, issue.1, p.21, 2013. ,
DOI : 10.1186/2047-9158-2-21
Histological and Direct Evidence for the Role of Complement in the Neuroinflammation of AD, Current Alzheimer Research, vol.8, issue.1, pp.34-58, 2011. ,
DOI : 10.2174/156720511794604589
Developmental vitamin D deficiency alters the expression of genes encoding mitochondrial, cytoskeletal and synaptic proteins in the adult rat brain, The Journal of Steroid Biochemistry and Molecular Biology, vol.103, issue.3-5, pp.538-545, 2007. ,
DOI : 10.1016/j.jsbmb.2006.12.096
URL : https://hal.archives-ouvertes.fr/hal-00320753
Gene expression profiling in equine polysaccharide storage myopathy revealed inflammation, glycogenesis inhibition, hypoxia and mitochondrial dysfunctions, BMC Veterinary Research, vol.5, issue.1, p.29, 2009. ,
DOI : 10.1186/1746-6148-5-29
URL : https://hal.archives-ouvertes.fr/inserm-00663617
Expansion of Functionally Anergic CD21-/low Marginal Zone-like B Cell Clones in Hepatitis C Virus Infection-Related Autoimmunity, The Journal of Immunology, vol.187, issue.12, pp.6550-6563, 2011. ,
DOI : 10.4049/jimmunol.1102022
Transcriptome analysis of muscle in horses suffering from recurrent exertional rhabdomyolysis revealed energetic pathway alterations and disruption in the cytosolic calcium regulation, Animal Genetics, vol.61, issue.Suppl. 2 ,
DOI : 10.1111/j.1365-2052.2011.02246.x
URL : https://hal.archives-ouvertes.fr/hal-00973744
Skeletal muscle alterations and exercise performance decrease in erythropoietin-deficient mice: a comparative study, BMC Medical Genomics, vol.100, issue.7, p.29, 2012. ,
DOI : 10.1182/blood-2002-01-0124
URL : https://hal.archives-ouvertes.fr/inserm-00742677
Developmental vitamin D deficiency alters brain protein expression in the adult rat: Implications for neuropsychiatric disorders, PROTEOMICS, vol.23, issue.90, pp.769-780, 2007. ,
DOI : 10.1002/pmic.200600392
URL : https://hal.archives-ouvertes.fr/hal-00320755
Production of interferon-?? by microglia, Multiple Sclerosis Journal, vol.156, issue.5, pp.558-564, 2006. ,
DOI : 10.1177/1352458506070763
IFN-?? Promotes Complement Expression and Attenuates Amyloid Plaque Deposition in Amyloid ?? Precursor Protein Transgenic Mice, The Journal of Immunology, vol.184, issue.9, pp.5333-5343, 2010. ,
DOI : 10.4049/jimmunol.0903382
Th17 Cell-Mediated Neuroinflammation Is Involved in Neurodegeneration of A??1-42-Induced Alzheimer???s Disease Model Rats, PLoS ONE, vol.23, issue.10, p.75786, 2013. ,
DOI : 10.1371/journal.pone.0075786.g006
The impact of neuroimmune changes on development of amyloid pathology; relevance to Alzheimer's disease, Immunology, vol.204, issue.Pt 11, pp.292-301, 2013. ,
DOI : 10.1111/imm.12156
A??1-42-RAGE Interaction Disrupts Tight Junctions of the Blood-Brain Barrier Via Ca2+-Calcineurin Signaling, Journal of Neuroscience, vol.32, issue.26, pp.8845-8854, 2012. ,
DOI : 10.1523/JNEUROSCI.6102-11.2012
IFN-?? Production by Amyloid ??-Specific Th1 Cells Promotes Microglial Activation and Increases Plaque Burden in a Mouse Model of Alzheimer's Disease, The Journal of Immunology, vol.190, issue.5, pp.2241-2251, 2013. ,
DOI : 10.4049/jimmunol.1200947
Regulation and Function of Class II Major Histocompatibility Complex, CD40, and B7 Expression in Macrophages and Microglia: Implications in Neurological Diseases, Journal of Neurovirology, vol.8, issue.6, pp.496-512, 2002. ,
DOI : 10.1080/13550280290100941
Reactive microglia express class I and class II major histocompatibility complex antigens in Alzheimer's disease, Brain Research, vol.523, issue.2, pp.273-280, 1990. ,
DOI : 10.1016/0006-8993(90)91496-4
Expression of CD74 is increased in neurofibrillary tangles in Alzheimer's disease, Molecular Neurodegeneration, vol.3, issue.1, p.13, 2008. ,
DOI : 10.1186/1750-1326-3-13
Macrophage Migration Inhibitory Factor Induces B Cell Survival by Activation of a CD74-CD44 Receptor Complex, Journal of Biological Chemistry, vol.283, issue.5, pp.2784-2792, 2008. ,
DOI : 10.1074/jbc.M703265200
CD74 interacts with APP and suppresses the production of A??, Molecular Neurodegeneration, vol.4, issue.1, p.41, 2009. ,
DOI : 10.1186/1750-1326-4-41
Human IRGM gene ???to be or not to be???, Seminars in Immunopathology, vol.40, issue.7, pp.437-444, 2010. ,
DOI : 10.1007/s00281-010-0224-x
p47 GTPases: regulators of immunity to intracellular pathogens, Nature Reviews Immunology, vol.84, issue.2, pp.47100-109, 2004. ,
DOI : 10.1146/annurev.biochem.63.1.949
Immune-related GTPase M (IRGM1) regulates neuronal autophagy in a mouse model of stroke, Autophagy, vol.96, issue.11, pp.1621-1627, 2012. ,
DOI : 10.1016/j.neulet.2008.08.077
Immune-related GTPase Irgm1 exacerbates experimental auto-immune encephalomyelitis by promoting the disruption of blood???brain barrier and blood???cerebrospinal fluid barrier, Molecular Immunology, vol.53, issue.1-2, pp.43-51, 2013. ,
DOI : 10.1016/j.molimm.2012.06.009
The p47 GTPase Lrg-47 (Irgm1) Links Host Defense and Hematopoietic Stem Cell Proliferation, Cell Stem Cell, vol.2, issue.1, pp.83-89, 2008. ,
DOI : 10.1016/j.stem.2007.10.007
Disruption of the Toxoplasma gondii Parasitophorous Vacuole by IFN??-Inducible Immunity-Related GTPases (IRG Proteins) Triggers Necrotic Cell Death, PLoS Pathogens, vol.47, issue.2, p.1000288, 2009. ,
DOI : 10.1371/journal.ppat.1000288.s017
Genetic deficiency of Irgm1 (LRG-47) suppresses induction of experimental autoimmune encephalomyelitis by promoting apoptosis of activated CD4+ T cells, The FASEB Journal, vol.24, issue.5, pp.1583-1592, 2010. ,
DOI : 10.1096/fj.09-137323
Balance of Irgm protein activities determines IFN-??-induced host defense, Journal of Leukocyte Biology, vol.85, issue.5, pp.877-885, 2009. ,
DOI : 10.1189/jlb.1008599
The Mouse Resistance Protein Irgm1 (LRG-47): A Regulator or an Effector of Pathogen Defense?, PLoS Pathogens, vol.10, issue.7, p.1001008, 2010. ,
DOI : 10.1371/journal.ppat.1001008.t001
A Gene Network Regulating Lysosomal Biogenesis and Function, Science, vol.325, pp.473-477, 2009. ,
DOI : 10.1126/science.1174447
TFEB Links Autophagy to Lysosomal Biogenesis, Science, vol.332, issue.6036, pp.1429-1433, 2011. ,
DOI : 10.1126/science.1204592
A Role for Presenilins in Autophagy Revisited: Normal Acidification of Lysosomes in Cells Lacking PSEN1 and PSEN2, Journal of Neuroscience, vol.32, issue.25, pp.8633-8648, 2012. ,
DOI : 10.1523/JNEUROSCI.0556-12.2012
The up-regulation of endosomal-lysosomal components in amyloid beta-resistant cells, J Neurochem, vol.73, pp.1477-1482, 1999. ,
The role of the endosomal/ lysosomal system in amyloid-beta production and the pathophysiology of Alzheimer's disease: Reexamining the spatial paradox from a lysosomal perspective, Journal of Alzheimer's Disease, vol.6, issue.1, pp.53-65, 2004. ,
DOI : 10.3233/JAD-2004-6107
The Alzheimer???s ??-secretase BACE1 localizes to normal presynaptic terminals and to dystrophic presynaptic terminals surrounding amyloid plaques, Acta Neuropathologica, vol.287, issue.31, pp.329-352, 2013. ,
DOI : 10.1007/s00401-013-1152-3
Inhibition of Glycogen Synthase Kinase-3 Ameliorates ??-Amyloid Pathology and Restores Lysosomal Acidification and Mammalian Target of Rapamycin Activity in the Alzheimer Disease Mouse Model: IN VIVO AND IN VITRO STUDIES, Journal of Biological Chemistry, vol.288, issue.2, pp.1295-1306, 2013. ,
DOI : 10.1074/jbc.M112.409250
The endosomal-lysosomal system of neurons in Alzheimer's disease pathogenesis: a review, Neurochemical Research, vol.25, issue.9/10, pp.1161-1172, 2000. ,
DOI : 10.1023/A:1007675508413
Site ?? Is Crucial for Two Routes of IFN??-Induced MHC Class I Transactivation: The ISRE-Mediated Route and a Novel Pathway Involving CIITA, Immunity, vol.6, issue.5, pp.601-611, 1997. ,
DOI : 10.1016/S1074-7613(00)80348-9
Activation of the MHC Class II Transactivator CIITA by Interferon-?? Requires Cooperative Interaction between Stat1 and USF-1, Immunity, vol.8, issue.2, pp.157-166, 1998. ,
DOI : 10.1016/S1074-7613(00)80468-9
An interferon gamma-regulated protein that binds the interferon-inducible enhancer element of major histocompatibility complex class I genes., Proceedings of the National Academy of Sciences, vol.87, issue.10, pp.3743-3747, 1990. ,
DOI : 10.1073/pnas.87.10.3743
IFN consensus sequence binding protein (ICSBP) is a conditional repressor of IFN inducible promoters, Int Immunol, vol.6, pp.1125-1131, 1994. ,
Two cis-DNA elements involved in myeloid-cell-specific expression and gamma interferon (IFN-gamma) activation of the human high-affinity Fc gamma receptor gene: a novel IFN regulatory mechanism., Molecular and Cellular Biology, vol.13, issue.4, pp.2182-2192, 1993. ,
DOI : 10.1128/MCB.13.4.2182
IRF8 Is a Critical Transcription Factor for Transforming Microglia into a Reactive Phenotype, Cell Reports, vol.1, issue.4, pp.334-340, 2012. ,
DOI : 10.1016/j.celrep.2012.02.014
The IRF Family Transcription Factors in Immunity and Oncogenesis, Annual Review of Immunology, vol.26, issue.1, pp.535-584, 2008. ,
DOI : 10.1146/annurev.immunol.26.021607.090400
IRF8 regulates myeloid and B lymphoid lineage diversification, Immunologic Research, vol.177, issue.1-3, pp.109-117, 2009. ,
DOI : 10.1007/s12026-008-8055-8
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2803682
Interferon Regulatory Factor 8 Regulates Pathways for Antigen Presentation in Myeloid Cells and during Tuberculosis, PLoS Genetics, vol.3, issue.6, p.1002097, 2011. ,
DOI : 10.1371/journal.pgen.1002097.s010
Irf8-Regulated Genomic Responses Drive Pathological Inflammation during Cerebral Malaria, PLoS Pathogens, vol.10, issue.7, p.100349133 ,
DOI : 10.1371/journal.ppat.1003491.s006
URL : http://doi.org/10.1371/journal.ppat.1003491
Transforming growth factor ??1 up-regulates interferon regulatory factor 8 during dendritic cell development, European Journal of Immunology, vol.5, issue.5, pp.1174-1183, 2007. ,
DOI : 10.1002/eji.200636504
Transforming growth factor-beta suppresses activation and proliferation of microglia in vitro, J Immunol, vol.151, pp.2150-2158, 1993. ,
Antigen presentation in the central nervous system. The inhibitory effect of IL-10 on MHC class II expression and production of cytokines depends on the inducing signals and the type of cell analyzed, J Immunol, vol.152, pp.2720-2728, 1994. ,
NADPH oxidase and reactive oxygen species contribute to alcohol-induced microglial activation and neurodegeneration, Journal of Neuroinflammation, vol.103, issue.Suppl 1 ,
DOI : 10.1186/1742-2094-9-5
NADPH oxidase and aging drive microglial activation, oxidative stress, and dopaminergic neurodegeneration following systemic LPS administration, Glia, vol.46, issue.Suppl 1, pp.855-868, 2013. ,
DOI : 10.1002/glia.22479
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3631289
Increased lipid peroxidation precedes amyloid plaque formation in an animal model of Alzheimer amyloidosis, J Neurosci, vol.21, pp.4183-4187, 2001. ,
Mitochondrial Alterations near Amyloid Plaques in an Alzheimer's Disease Mouse Model, Journal of Neuroscience, vol.33, issue.43, pp.17042-17051, 2013. ,
DOI : 10.1523/JNEUROSCI.1836-13.2013
Quantitative proteomic a nalysis of the hippocampus in the 5XFAD mouse model at early stages of Alzheimer's disease pathology, J Alzheimers Dis, vol.36, pp.321-334, 2013. ,
The use of interferon-gamma therapy in chronic granulomatous disease. Recent Patents Anti-infective drug Dis, pp.225-230, 2008. ,
JAK/STAT Signaling Pathway Regulates Nox1 and Nox4-Based NADPH Oxidase in Human Aortic Smooth Muscle Cells, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.30, issue.1, pp.105-112, 2010. ,
DOI : 10.1161/ATVBAHA.109.193896
In vitro activation of mouse neutrophils by recombinant human interferon-gamma: Increased phagocytosis and release of reactive oxygen species and pro-inflammatory cytokines, International Immunopharmacology, vol.18, issue.2, pp.228-235, 2014. ,
DOI : 10.1016/j.intimp.2013.12.010
p40phox: The last NADPH oxidase subunit, Blood Cells, Molecules, and Diseases, vol.35, issue.2, pp.291-302, 2005. ,
DOI : 10.1016/j.bcmd.2005.06.010
Fc??R-stimulated activation of the NADPH oxidase: phosphoinositide-binding protein p40phox regulates NADPH oxidase activity after enzyme assembly on the phagosome, Blood, vol.112, issue.9, pp.3867-3877, 2008. ,
DOI : 10.1182/blood-2007-11-126029
Vav Proteins in Neutrophils Are Required for Fc??R-Mediated Signaling to Rac GTPases and Nicotinamide Adenine Dinucleotide Phosphate Oxidase Component p40(phox), The Journal of Immunology, vol.177, issue.9, pp.6388-6397, 2006. ,
DOI : 10.4049/jimmunol.177.9.6388
Activation of NADPH Oxidase in Alzheimer's Disease Brains, Biochemical and Biophysical Research Communications, vol.273, issue.1, pp.5-9, 2000. ,
DOI : 10.1006/bbrc.2000.2897
??-Amyloid Peptides Induce Mitochondrial Dysfunction and Oxidative Stress in Astrocytes and Death of Neurons through Activation of NADPH Oxidase, Journal of Neuroscience, vol.24, issue.2, pp.565-575, 2004. ,
DOI : 10.1523/JNEUROSCI.4042-03.2004
CD40 Expression by Microglial Cells Is Required for Their Completion of a Two-Step Activation Process during Central Nervous System Autoimmune Inflammation, The Journal of Immunology, vol.176, issue.3, pp.1402-1410, 2006. ,
DOI : 10.4049/jimmunol.176.3.1402
Expression of immunohistochemical markers on microglia in Creutzfeldt- Jakob disease and Alzheimer's disease: morphometric study and review of the literature, Folia Neuropathol, vol.50, pp.74-84, 2012. ,
Acute and Chronic Stress-Induced Disturbances of Microglial Plasticity, Phenotype and Function, Current Drug Targets, vol.14, issue.11, pp.1262-1276, 2013. ,
DOI : 10.2174/13894501113149990208
Identification of Fc??RI, II and III on normal human brain ramified microglia and on microglia in senile plaques in Alzheimer's disease, Journal of Neuroimmunology, vol.48, issue.1, pp.71-79, 1993. ,
DOI : 10.1016/0165-5728(93)90060-C
The Rac target NADPH oxidase p67phox interacts preferentially with Rac2 rather than Rac1, J Biol Chem, vol.271, pp.83-88, 1996. ,
Inhibition of superoxide production in B lymphocytes by rac antisense oligonucleotides, J Biol Chem, vol.267, pp.20540-20542, 1992. ,
Microglial chemotaxis, activation, and phagocytosis of amyloid ??-peptide as linked phenomena in Alzheimer's disease, Neurochemistry International, vol.39, issue.5-6, pp.333-340, 2001. ,
DOI : 10.1016/S0197-0186(01)00040-7
Ineffective phagocytosis of amyloid-?? by macrophages of Alzheimer's disease patients, Journal of Alzheimer's Disease, vol.7, issue.3, pp.221-232, 2005. ,
DOI : 10.3233/JAD-2005-7304
Microglial Phagocytosis of Fibrillar ??-Amyloid through a ??1 Integrin-Dependent Mechanism, Journal of Neuroscience, vol.24, issue.44, pp.9838-9846, 2004. ,
DOI : 10.1523/JNEUROSCI.2557-04.2004
LPS receptor (CD14): a receptor for phagocytosis of Alzheimer's amyloid peptide, Brain, vol.128, issue.8, pp.1778-1789, 2005. ,
DOI : 10.1093/brain/awh531
Colony-stimulating factor 1 receptor (CSF1R) signaling in injured neurons facilitates protection and survival, The Journal of Experimental Medicine, vol.1, issue.1, pp.157-172, 2013. ,
DOI : 10.1016/j.neulet.2004.06.020
as Risk Factor for Alzheimer's Disease, New England Journal of Medicine, vol.368, issue.2, pp.182-184, 2013. ,
DOI : 10.1056/NEJMe1213157
variants in Alzheimer's disease, N Engl J Med, vol.368, pp.2117-127, 2013. ,
Associated with the Risk of Alzheimer's Disease, New England Journal of Medicine, vol.368, issue.2, pp.107-116, 2013. ,
DOI : 10.1056/NEJMoa1211103
TREM2-Transduced Myeloid Precursors Mediate Nervous Tissue Debris Clearance and Facilitate Recovery in an Animal Model of Multiple Sclerosis, PLoS Medicine, vol.436, issue.4, p.124, 2007. ,
DOI : 10.1371/journal.pmed.0040124.st003
Blockade of TREM-2 exacerbates experimental autoimmune encephalomyelitis, European Journal of Immunology, vol.164, issue.5, pp.1290-1301, 2007. ,
DOI : 10.1002/eji.200636837
TREM2 is upregulated in amyloid plaque-associated microglia in aged APP23 transgenic mice, Glia, vol.177, issue.13, pp.1438-1447, 2008. ,
DOI : 10.1002/glia.20710
Enhanced Toll-like receptor responses in the absence of signaling adaptor DAP12, Nature Immunology, vol.19, issue.6, pp.579-586, 2005. ,
DOI : 10.1016/S0022-1759(98)00204-X
Cutting Edge: Inhibition of TLR and FcR Responses in Macrophages by Triggering Receptor Expressed on Myeloid Cells (TREM)-2 and DAP12, The Journal of Immunology, vol.177, issue.4, pp.2051-2055, 2006. ,
DOI : 10.4049/jimmunol.177.4.2051
Increased Circulating Insulin-like Growth Factor-1 in Late-onset Alzheimer's Disease, Journal of Alzheimer's Disease, vol.12, issue.4, pp.285-290, 2007. ,
DOI : 10.3233/JAD-2007-12401
The Role of IGF-1 Receptor and Insulin Receptor Signaling for the Pathogenesis of Alzheimers Disease: From Model Organisms to Human Disease, Current Alzheimer Research, vol.6, issue.3, pp.213-223, 2009. ,
DOI : 10.2174/156720509788486527
IGF-1 Can Either Protect Against or Increase LPS-Induced Damage in the Developing Rat Brain, Pediatric Research, vol.51, issue.6, pp.579-584, 2010. ,
DOI : 10.1203/PDR.0b013e3181dc240f
Phosphatidylinositol 3-kinase-mediated regulation of neuronal apoptosis and necrosis by insulin and IGF-I, Journal of Neurobiology, vol.65, issue.4, pp.536-546, 1999. ,
DOI : 10.1002/(SICI)1097-4695(19990615)39:4<536::AID-NEU7>3.0.CO;2-J
Neuronal Death by Oxidative Stress Involves Activation of FOXO3 through a Two-Arm Pathway That Activates Stress Kinases and Attenuates Insulin-like Growth Factor I Signaling, Molecular Biology of the Cell, vol.19, issue.5, pp.2014-2025, 2008. ,
DOI : 10.1091/mbc.E07-08-0811
Astrocyte-Specific Overexpression of Insulin-Like Growth Factor-1 ,
Prostaglandin E2 is a novel inducer of oncostatin-M expression in macrophages and microglia, J Neurosci, vol.22, pp.5334-5343, 2002. ,
Oncostatin M is a neuroprotective cytokine that inhibits excitotoxic injury in vitro and in vivo, The FASEB Journal, vol.20, issue.13, pp.2369-2371, 2006. ,
DOI : 10.1096/fj.06-5850fje
Prostaglandin E2 Induces Oncostatin M Expression in Human Chronic Wound Macrophages through Axl Receptor Tyrosine Kinase Pathway, The Journal of Immunology, vol.189, issue.5, pp.2563-2573, 2012. ,
DOI : 10.4049/jimmunol.1102762
Protective Role of STAT3 in NMDA and Glutamate-Induced Neuronal Death: Negative Regulatory Effect of SOCS3, PLoS ONE, vol.103, issue.11, p.50874, 2012. ,
DOI : 10.1371/journal.pone.0050874.s002
Role of progranulin as a biomarker for Alzheimer???s disease, Biomarkers in Medicine, vol.4, issue.1, pp.37-50, 2010. ,
DOI : 10.2217/bmm.09.82
The Growth Factor Progranulin Binds to TNF Receptors and Is Therapeutic Against Inflammatory Arthritis in Mice, Science, vol.332, issue.6028, pp.478-484, 2011. ,
DOI : 10.1126/science.1199214
Conversion of Proepithelin to Epithelins, Cell, vol.111, issue.6, pp.867-878, 2002. ,
DOI : 10.1016/S0092-8674(02)01141-8
HDL/Apolipoprotein A-I Binds to Macrophage-Derived Progranulin and Suppresses its Conversion into Proinflammatory Granulins, Journal of Atherosclerosis and Thrombosis, vol.17, issue.6, pp.568-577, 2010. ,
DOI : 10.5551/jat.3921
Galantamine Slows Down Plaque Formation and Behavioral Decline in the 5XFAD Mouse Model of Alzheimer???s Disease, PLoS ONE, vol.40, issue.2, p.89454, 2014. ,
DOI : 10.1371/journal.pone.0089454.g007